Bellerophon announces poster presentation at upcoming american thoracic society 2022 international conference

Warren, n.j., may 12, 2022 (globe newswire) -- bellerophon therapeutics, inc. (nasdaq: blph) (“bellerophon” or the “company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced a poster presentation at the upcoming american thoracis society (ats) 2022 international conference, being held may 13-18, 2022, in san francisco, ca.
BLPH Ratings Summary
BLPH Quant Ranking